piritrexim has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Christopherson, RI; Crisp, LB; Schoettle, SL; Szabados, E | 1 |
| Christopherson, RI; Lyons, SD | 1 |
3 other study(ies) available for piritrexim and Leukemia L 1210
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Mechanisms of inhibition of amido phosphoribosyltransferase from mouse L1210 leukemia cells.
Topics: Adenosine Monophosphate; Amidophosphoribosyltransferase; Animals; Antineoplastic Agents; Binding, Competitive; Centrifugation, Density Gradient; Chromatography, Thin Layer; Kinetics; Leukemia L1210; Mice; Pyrimidines; Radioligand Assay; Structure-Activity Relationship; Substrate Specificity | 1997 |
Antifolates induce primary inhibition of the de novo purine pathway prior to 5-aminoimidazole-4-carboxamide ribotide transformylase in leukemia cells.
Topics: Acyltransferases; Animals; Azaserine; Folic Acid Antagonists; Hydroxymethyl and Formyl Transferases; Leukemia L1210; Methotrexate; Phosphoribosylaminoimidazolecarboxamide Formyltransferase; Purine Nucleotides; Purines; Pyrimidines; Tumor Cells, Cultured | 1991 |